1-9 of 9
Marko Kornmann
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract PO-092: Influence of the IL-13-receptor alpha 1 chain on the malignant phenotype of pancreatic cancer cells

Jingwei Shi, Marko Kornmann, Benno Traub
Journal: Cancer Research
Cancer Res (2021) 81 (22_Supplement): PO-092.
https://doi.org/10.1158/1538-7445.PANCA21-PO-092
Published: 15 November 2021
View articletitled, Abstract PO-092: Influence of the IL-13-receptor alpha 1 chain on the malignant phenotype of pancreatic cancer cells
Journal Articles

Abstract PO-093: JNK2 suppresses the growth and invasion of pancreatic cancer and is opposed by JNK1

Jingwei Shi, Xiaodong Tian, Marko Kornmann, Benno Traub
Journal: Cancer Research
Cancer Res (2021) 81 (22_Supplement): PO-093.
https://doi.org/10.1158/1538-7445.PANCA21-PO-093
Published: 15 November 2021
View articletitled, Abstract PO-093: JNK2 suppresses the growth and invasion of pancreatic cancer and is opposed by JNK1
Journal Articles

Preclinical Characterization of Novel Chordoma Cell Systems and Their Targeting by Pharmocological Inhibitors of the CDK4/6 Cell-Cycle Pathway

Adrian von Witzleben, Lukas T. Goerttler, Ralf Marienfeld, Holger Barth, André Lechel, Kevin Mellert, Michael Böhm, Marko Kornmann, Regine Mayer-Steinacker, Alexandra von Baer, Markus Schultheiss, Adrienne M. Flanagan, Peter Möller, Silke Brüderlein, Thomas F.E. Barth
Journal: Cancer Research
Cancer Res (2015) 75 (18): 3823–3831.
https://doi.org/10.1158/0008-5472.CAN-14-3270
Published: 14 September 2015
View articletitled, Preclinical Characterization of Novel Chordoma Cell Systems and Their Targeting by Pharmocological Inhibitors of the CDK4/6 Cell-Cycle Pathway
Open the PDF for Preclinical Characterization of Novel Chordoma Cell Systems and Their Targeting by Pharmocological Inhibitors of the CDK4/6 Cell-Cycle Pathway in another window
Includes: Supplementary data
Journal Articles

Prognostic factors influencing the outcome of patients with colorectal cancer receiving adjuvant 5-FU-based chemotherapy.

Marko Kornmann, Ludger Staib, Silvia Sander, Doris Henne-Bruns, Karl Link
Journal: Cancer Research
Cancer Res (2008) 68 (9_Supplement): 4459.
Published: 01 May 2008
View articletitled, Prognostic factors influencing the outcome of patients with colorectal cancer receiving adjuvant 5-FU-based chemotherapy.
Journal Articles

Exon III splicing of FGF receptor 1 is modulated by growth factors and cyclin D1

Marko Kornmann, Guowei Chen, Jian Wang, Zhanbing Liu
Journal: Cancer Research
Cancer Res (2008) 68 (9_Supplement): 3605.
Published: 01 May 2008
View articletitled, Exon III splicing of FGF receptor 1 is modulated by growth factors and cyclin D1
Journal Articles

Identification of a Fibroblast Growth Factor Receptor 1 Splice Variant That Inhibits Pancreatic Cancer Cell Growth

Zhanbing Liu, Nicola Neiss, Shaoxia Zhou, Doris Henne-Bruns, Murray Korc, Max Bachem, Marko Kornmann
Journal: Cancer Research
Cancer Res (2007) 67 (6): 2712–2719.
https://doi.org/10.1158/0008-5472.CAN-06-3843
Published: 15 March 2007
View articletitled, Identification of a Fibroblast Growth Factor Receptor 1 Splice Variant That Inhibits Pancreatic Cancer Cell Growth
Open the PDF for Identification of a Fibroblast Growth Factor Receptor 1 Splice Variant That Inhibits Pancreatic Cancer Cell Growth in another window
Journal Articles

The human IIIb-mRNA splice variant of FGFR1 is a functional transmembrane tyrosine kinase receptor and inhibits pancreatic cancer cell growth

Marko Kornmann, Zhangbing Liu, Susi Meier, Doris Henne-Bruns, Murray Korc
Journal: Cancer Research
Cancer Res (2005) 65 (9_Supplement): 1076–1077.
Published: 01 May 2005
View articletitled, The human IIIb-mRNA splice variant of FGFR1 is a functional transmembrane tyrosine kinase receptor and inhibits pancreatic cancer cell growth
Journal Articles

Inhibition of Cyclin D1 Expression in Human Pancreatic Cancer Cells Is Associated with Increased Chemosensitivity and Decreased Expression of Multiple Chemoresistance Genes

Marko Kornmann, Kathleen D. Danenberg, Nadir Arber, Hans G. Beger, Peter V. Danenberg, Murray Korc
Journal: Cancer Research
Cancer Res (1999) 59 (14): 3505–3511.
Published: 15 July 1999
View articletitled, Inhibition of Cyclin D1 Expression in Human Pancreatic Cancer Cells Is Associated with Increased Chemosensitivity and Decreased Expression of Multiple Chemoresistance Genes
Open the PDF for Inhibition of Cyclin D1 Expression in Human Pancreatic Cancer Cells Is Associated with Increased Chemosensitivity and Decreased Expression of Multiple Chemoresistance Genes in another window
Journal Articles

Enhanced Expression of the Insulin Receptor Substrate-2 Docking Protein in Human Pancreatic Cancer

Marko Kornmann, Haruhisa Maruyama, Uwe Bergmann, Pam Tangvoranuntakul, Hans G. Beger, Morris F. White, Murray Korc
Journal: Cancer Research
Cancer Res (1998) 58 (19): 4250–4254.
Published: 01 October 1998
View articletitled, Enhanced Expression of the Insulin Receptor Substrate-2 Docking Protein in Human Pancreatic Cancer
Open the PDF for Enhanced Expression of the Insulin Receptor Substrate-2 Docking Protein in Human Pancreatic Cancer in another window